709.33
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$736.72
Aprire:
$736.695
Volume 24 ore:
20.05M
Relative Volume:
1.18
Capitalizzazione di mercato:
$1.81T
Reddito:
$214.96B
Utile/perdita netta:
$70.59B
Rapporto P/E:
25.79
EPS:
27.5066
Flusso di cassa netto:
$48.25B
1 W Prestazione:
-1.30%
1M Prestazione:
+5.35%
6M Prestazione:
+4.79%
1 anno Prestazione:
-0.39%
Meta Platforms Inc Stock (META) Company Profile
Nome
Meta Platforms Inc
Settore
Industria
Telefono
650-543-4800
Indirizzo
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, RDDT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
META
Meta Platforms Inc
|
709.33 | 1.81T | 214.96B | 70.59B | 48.25B | 27.51 |
|
GOOGL
Alphabet Inc
|
340.59 | 4.17T | 446.32B | 244.21B | 53.27B | 19.91 |
|
GOOG
Alphabet Inc
|
336.91 | 4.12T | 446.32B | 244.21B | 53.27B | 19.91 |
|
SPOT
Spotify Technology Sa
|
530.46 | 109.05B | 20.32B | 3.16B | 3.82B | 12.55 |
|
RDDT
Reddit Inc
|
156.14 | 30.04B | 2.47B | 707.54M | 868.73M | 3.5267 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2026-09-25 | Reiterato | Canaccord Genuity | Buy |
| 2026-09-25 | Reiterato | Deutsche Bank | Buy |
| 2026-09-25 | Reiterato | Piper Sandler | Overweight |
| 2026-09-25 | Reiterato | TD Cowen | Buy |
| 2026-09-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-09-21 | Reiterato | Wells Fargo | Overweight |
| 2026-09-10 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2026-08-27 | Reiterato | Rosenblatt | Buy |
| 2026-08-27 | Reiterato | Truist | Buy |
| 2026-07-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Ripresa | Wedbush | Neutral |
| 2026-07-10 | Reiterato | Citizens | Mkt Outperform |
| 2026-07-07 | Aggiornamento | Erste Group | Hold → Buy |
| 2026-06-02 | Aggiornamento | Arete | Neutral → Buy |
| 2026-05-20 | Reiterato | Wells Fargo | Overweight |
| 2026-05-05 | Reiterato | Mizuho | Outperform |
| 2026-04-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Reiterato | Wolfe Research | Outperform |
| 2026-04-09 | Reiterato | Rosenblatt | Buy |
| 2026-04-02 | Downgrade | Erste Group | Buy → Hold |
| 2026-03-30 | Reiterato | Morgan Stanley | Overweight |
| 2026-03-05 | Downgrade | Arete | Buy → Neutral |
| 2026-03-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2026-02-23 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Canaccord Genuity | Buy |
| 2026-01-29 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Reiterato | Deutsche Bank | Buy |
| 2026-01-29 | Reiterato | Evercore ISI | Outperform |
| 2026-01-29 | Reiterato | Guggenheim | Buy |
| 2026-01-29 | Reiterato | JP Morgan | Overweight |
| 2026-01-29 | Reiterato | Jefferies | Buy |
| 2026-01-29 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Reiterato | Mizuho | Outperform |
| 2026-01-29 | Reiterato | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Reiterato | Morgan Stanley | Overweight |
| 2026-01-29 | Reiterato | Piper Sandler | Overweight |
| 2026-01-29 | Reiterato | Pivotal Research Group | Buy |
| 2026-01-29 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-29 | Reiterato | Roth Capital | Buy |
| 2026-01-29 | Reiterato | Stifel | Buy |
| 2026-01-29 | Reiterato | UBS | Buy |
| 2026-01-29 | Reiterato | Wedbush | Outperform |
| 2026-01-29 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Wolfe Research | Outperform |
| 2026-01-26 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Reiterato | Raymond James | Strong Buy |
| 2026-01-26 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Reiterato | Stifel | Buy |
| 2026-01-13 | Reiterato | TD Cowen | Buy |
| 2026-01-12 | Reiterato | Wells Fargo | Overweight |
| 2026-01-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Reiterato | Guggenheim | Buy |
| 2025-12-04 | Aggiornamento | Arete | Neutral → Buy |
| 2025-11-24 | Iniziato | BNP Paribas Exane | Outperform |
| 2025-11-10 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-30 | Reiterato | Barclays | Overweight |
| 2025-10-30 | Reiterato | Bernstein | Outperform |
| 2025-10-30 | Reiterato | BofA Securities | Buy |
| 2025-10-30 | Reiterato | Citigroup | Buy |
| 2025-10-30 | Reiterato | JP Morgan | Overweight |
| 2025-10-30 | Reiterato | Jefferies | Buy |
| 2025-10-30 | Reiterato | Mizuho | Outperform |
| 2025-10-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Reiterato | Piper Sandler | Overweight |
| 2025-10-30 | Reiterato | Stifel | Buy |
| 2025-10-30 | Downgrade | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Reiterato | Oppenheimer | Outperform |
| 2025-10-07 | Reiterato | Wells Fargo | Overweight |
| 2025-09-30 | Iniziato | Mizuho | Outperform |
| 2025-07-31 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-07-31 | Reiterato | Bernstein | Outperform |
| 2025-07-31 | Reiterato | BofA Securities | Buy |
| 2025-07-31 | Reiterato | Citigroup | Buy |
| 2025-07-31 | Reiterato | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Reiterato | JP Morgan | Overweight |
| 2025-07-31 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Reiterato | Morgan Stanley | Overweight |
| 2025-07-31 | Reiterato | Oppenheimer | Outperform |
| 2025-07-31 | Reiterato | Pivotal Research Group | Buy |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-31 | Reiterato | UBS | Buy |
| 2025-07-31 | Reiterato | Wedbush | Outperform |
| 2025-07-31 | Reiterato | Wells Fargo | Overweight |
| 2025-07-28 | Reiterato | Guggenheim | Buy |
| 2025-07-16 | Reiterato | Canaccord Genuity | Buy |
| 2025-07-03 | Aggiornamento | Needham | Underperform → Hold |
| 2025-06-26 | Reiterato | UBS | Buy |
| 2025-06-24 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | BofA Securities | Buy |
| 2025-05-01 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | Evercore ISI | Outperform |
| 2025-05-01 | Reiterato | Goldman | Buy |
| 2025-05-01 | Reiterato | Guggenheim | Buy |
| 2025-05-01 | Reiterato | JP Morgan | Overweight |
| 2025-05-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Reiterato | MoffettNathanson | Buy |
| 2025-05-01 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Reiterato | Morgan Stanley | Overweight |
| 2025-05-01 | Reiterato | Oppenheimer | Outperform |
| 2025-05-01 | Reiterato | Piper Sandler | Overweight |
| 2025-05-01 | Reiterato | Pivotal Research Group | Buy |
| 2025-05-01 | Reiterato | Raymond James | Strong Buy |
| 2025-05-01 | Reiterato | Rosenblatt | Buy |
| 2025-05-01 | Reiterato | Roth Capital | Buy |
| 2025-05-01 | Reiterato | Stifel | Buy |
| 2025-05-01 | Reiterato | Truist | Buy |
| 2025-05-01 | Reiterato | UBS | Buy |
| 2025-05-01 | Reiterato | Wedbush | Outperform |
| 2025-04-14 | Reiterato | Citigroup | Buy |
| 2025-04-10 | Reiterato | Piper Sandler | Overweight |
| 2025-01-30 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Reiterato | BofA Securities | Buy |
| 2025-01-22 | Reiterato | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Reiterato | Jefferies | Buy |
| 2025-01-03 | Reiterato | Wolfe Research | Outperform |
| 2024-10-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-11 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-09 | Reiterato | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Iniziato | Pivotal Research Group | Buy |
| 2024-09-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Iniziato | DA Davidson | Buy |
| 2024-09-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Reiterato | BofA Securities | Buy |
| 2024-07-19 | Reiterato | Oppenheimer | Outperform |
| 2024-07-16 | Iniziato | Wolfe Research | Outperform |
| 2024-07-10 | Reiterato | TD Cowen | Buy |
| 2024-07-08 | Reiterato | Wells Fargo | Overweight |
| 2024-07-01 | Reiterato | Raymond James | Strong Buy |
| 2024-06-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-05-02 | Iniziato | Exane BNP Paribas | Underperform |
| 2024-04-25 | Reiterato | Oppenheimer | Outperform |
| 2024-04-15 | Reiterato | Citigroup | Buy |
| 2024-04-11 | Reiterato | Piper Sandler | Overweight |
| 2024-04-08 | Reiterato | Oppenheimer | Outperform |
| 2024-04-04 | Reiterato | Jefferies | Buy |
| 2024-02-02 | Reiterato | Guggenheim | Buy |
| 2024-02-02 | Reiterato | JMP Securities | Mkt Outperform |
| 2024-02-02 | Reiterato | JP Morgan | Overweight |
| 2024-02-02 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Reiterato | Mizuho | Buy |
| 2024-02-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Reiterato | Morgan Stanley | Overweight |
| 2024-02-02 | Reiterato | Oppenheimer | Outperform |
| 2024-02-02 | Reiterato | Piper Sandler | Overweight |
| 2024-02-02 | Reiterato | ROTH MKM | Buy |
| 2024-02-02 | Reiterato | Raymond James | Strong Buy |
| 2024-02-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-02-02 | Reiterato | Seaport Research Partners | Buy |
| 2024-02-02 | Reiterato | Stifel | Buy |
| 2024-02-02 | Reiterato | Susquehanna | Positive |
| 2024-02-02 | Reiterato | TD Cowen | Outperform |
| 2024-02-02 | Reiterato | UBS | Buy |
| 2024-02-02 | Reiterato | Wedbush | Outperform |
| 2024-02-02 | Reiterato | Wells Fargo | Overweight |
| 2024-02-02 | Reiterato | Wolfe Research | Outperform |
| 2024-01-23 | Reiterato | Citigroup | Buy |
| 2024-01-17 | Reiterato | Piper Sandler | Overweight |
| 2024-01-17 | Reiterato | Wells Fargo | Overweight |
| 2024-01-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2023-12-20 | Ripresa | Raymond James | Strong Buy |
| 2023-10-24 | Iniziato | Seaport Research Partners | Buy |
| 2023-08-22 | Iniziato | Wedbush | Outperform |
| 2023-08-01 | Reiterato | Argus | Buy |
| 2023-07-28 | Aggiornamento | China Renaissance | Hold → Buy |
| 2023-07-27 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Reiterato | Mizuho | Buy |
| 2023-07-25 | Aggiornamento | New Street | Neutral → Buy |
| 2023-07-19 | Reiterato | Jefferies | Buy |
| 2023-07-19 | Reiterato | Truist | Buy |
| 2023-07-17 | Reiterato | Credit Suisse | Outperform |
| 2023-07-17 | Reiterato | Goldman | Buy |
| 2023-07-17 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-07-13 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Reiterato | Deutsche Bank | Buy |
| 2023-06-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-05-15 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-04-27 | Reiterato | Credit Suisse | Outperform |
| 2023-04-27 | Reiterato | Deutsche Bank | Buy |
| 2023-04-27 | Reiterato | Evercore ISI | Outperform |
| 2023-04-27 | Reiterato | Goldman | Buy |
| 2023-04-27 | Reiterato | Guggenheim | Buy |
| 2023-04-27 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-04-27 | Reiterato | JP Morgan | Overweight |
| 2023-04-27 | Reiterato | Mizuho | Buy |
| 2023-04-27 | Reiterato | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Reiterato | Morgan Stanley | Overweight |
| 2023-04-27 | Reiterato | Oppenheimer | Outperform |
| 2023-04-27 | Reiterato | Piper Sandler | Overweight |
| 2023-04-27 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-27 | Reiterato | Raymond James | Outperform |
| 2023-04-27 | Reiterato | Robert W. Baird | Outperform |
| 2023-04-27 | Reiterato | Rosenblatt | Buy |
| 2023-04-27 | Reiterato | Stifel | Buy |
| 2023-04-27 | Reiterato | TD Cowen | Market Perform |
| 2023-04-27 | Reiterato | Truist | Buy |
| 2023-04-27 | Reiterato | Wolfe Research | Outperform |
Mostra tutto
Meta Platforms Inc Borsa (META) Ultime notizie
Inflation Pressures Rise as Services Activity Weakens - Zacks Investment Research
First Week of Q3 Earnings in the Books - Zacks Investment Research
This Unstoppable Vanguard ETF Could Turn $500 Per Month Into $1 Million Over the Long Term - The Motley Fool
The Stock Market Is Doing Something for Only the 3rd Time in 156 Years, and History Is Clear a Crash May be Hiding in Plain Sight - The Motley Fool
Cathie Wood Is Buying Shares of This Bargain “Magnificent Seven” Stock Before Oct. 21. Should You? - The Motley Fool
CoreWeave Stock Is Crashing. This Could Be Great News for SpaceX Investors. - The Motley Fool
This Dividend King Is Getting In on the AI Energy Boom With Its Recent Deal with Google. Is It a Buy? - The Motley Fool
Billionaires Are Selling These 6 Artificial Intelligence (AI) Stocks. Should You Follow? - The Motley Fool
Prediction: A $10,000 Investment in This Artificial Intelligence (AI) Hardware Stock Will At Least Double by 2030 (Hint: It’s Not Nvidia or Micron) - The Motley Fool
SpaceX Has Climbed 15% From Its IPO Price. Here’s Where History Says It Will Be After 1 Year. - The Motley Fool
Not Nvidia. Not Cisco. This Is the AI Networking Stock Quietly Wiring Every Data Center - The Motley Fool
3 Chip Stocks to Buy Before Big Tech Reports Its Spending Plans - The Motley Fool
Why This Market Washout Will Spark a Year-End Rally - Zacks Investment Research
These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead - The Motley Fool
Is It Really "Safe" to Invest in Tech ETFs Right Now? Here's What History Suggests. - The Motley Fool
Form 4 Arista Networks For: 15 October By Investing.com - Investing.com Canada
Meta's Muse Agent Is a Massive Hit. I'm Still Not Sold on Meta Stock. - The Motley Fool
The Stock Market Will Look Completely Different by 2030. This Is the Stock I'm Buying Before It Does. - The Motley Fool
BLK Q3 Earnings Call Puts AI Financing and Fees in Focus - Zacks Investment Research
Big Tech Will Spend $745 Billion on AI This Year. These Stocks Get Paid on Every Dollar. - The Motley Fool
INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP AnnouncesHIMS - GlobeNewswire Inc.
Agentic AI Could Push This Trillion-Dollar Chipmaker to New Heights, According to Wall Street Analysts - The Motley Fool
Is Vident U.S. Equity Strategy ETF (VUSE) a Strong ETF Right Now? - Zacks Investment Research
Apple Could Dominate the Agentic AI Market With Siri. Just Not This Siri. - The Motley Fool
Not Memory. Not Energy. This Is the Biggest Bottleneck in Artificial Intelligence, and These Are the Companies That Can Benefit. - The Motley Fool
The Stock Market Is Echoing a Warning From the Dot-Com Bubble, and History Says Investors Should Make This 1 Move - The Motley Fool
Meta Platforms, Inc. (META) Stock Price, News, Quote & History - Yahoo! Finance Canada
Anthropic Just Became the First Company in History To Reach This Milestone. Here's What It Means for AI Stocks - The Motley Fool
Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action - GlobeNewswire Inc.
Meta Platforms (META) COO and related entities sell shares at $728.10 under a trading plan - Stock Titan
Jim Cramer Calls CoreWeave the "Real Deal," but the Stock Crashed 15% the Very Next Day. Should You Buy the Dip? - The Motley Fool
Form 144 Meta Platforms For: 14 October By Investing.com - Investing.com Nigeria
Form 4 Meta Platforms Inc For: 14 October By Investing.com - Investing.com Nigeria
Musings About the Agentic Future - The Motley Fool
3 Trillion-Dollar Giants That Could Be the Next Big Stock-Split Plays - The Motley Fool
Nvidia Talked Up Generative AI 2 Weeks Before ChatGPT. The Clues Hold Up. - The Motley Fool
Should You Buy Alphabet Before Oct. 28? - The Motley Fool
Zacks Investment Ideas feature highlights: Meta Platform, Micron, SK Hynix, SanDisk and and ASML - Zacks Investment Research
Prediction: $5,000 Invested in Taiwan Semiconductor Could Be Worth This Much by 2030 - The Motley Fool
Alphabet vs. Meta Platforms: Here's What Revenue Trends Tell Investors About These Media Giants Turned Artificial Intelligence Companies - The Motley Fool
Form 4 Alphabet Inc Class A For: 14 October By Investing.com - Investing.com Canada
Why the Market Dipped But Meta Platforms (META) Gained Today - Zacks Investment Research
Bull Market Just Completed Year 4. Will It Finish Year 5? Here's What History Says. - The Motley Fool
Bearish AI Headlines: An Artificial Wave of Panic - Zacks Investment Research
Is Meta Platforms Stock Heading for $1,000? - The Motley Fool
Is Oklo Stock Your Ticket to Becoming a Millionaire? - The Motley Fool
AppLovin vs. Reddit: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Meta Platforms Rises 12% in 3 Months: Buy, Sell, or Hold the Stock? - Zacks Investment Research
Meta Platforms, Inc. (META) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Broadcom vs. Nvidia: The AI Revolution Is Big Enough for Both. Here's the Better Buy. - The Motley Fool
Meta Platforms Inc Azioni (META) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Meta Platforms Inc Azioni (META) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Oct 12 '26 |
Sale |
728.10 |
629 |
457,975 |
1,004 |
| Olivan Javier | Officer |
Oct 12 '26 |
Proposed Sale |
728.10 |
1,575 |
1,146,757 |
0 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
629 |
457,962 |
1,061 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
946 |
688,764 |
7,878 |
| Olivan Javier | Officer |
Oct 05 '26 |
Proposed Sale |
728.08 |
1,575 |
1,146,726 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
748.91 |
629 |
471,064 |
1,118 |
| Olivan Javier | Officer |
Sep 28 '26 |
Proposed Sale |
749.82 |
1,575 |
1,180,966 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
750.42 |
946 |
709,902 |
8,824 |
| Zuckerberg Mark | COB and CEO |
Sep 24 '26 |
Sale |
777.44 |
27,474 |
21,359,454 |
0 |
| Zuckerberg Mark | Officer |
Sep 24 '26 |
Proposed Sale |
777.44 |
27,474 |
21,359,454 |
0 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):